BMC cancer
Talazoparib in patients with BRCA mutant metastatic breast or ovarian carcinoma: results of early access program.
Mehmet Ali Nahit Sendur, Mutlu Hizal, Burcu Çakar, Oktay Halit Aktepe, Emrah Eraslan, Zafer Arık, İsmail Erturk, Sercan Aksoy, Semra Paydaş, Serkan Değirmencioğlu, Cihan Erol, Necla Demir, Gülcan Bulut, Naziye Ak, Metin Özkan
Published: 202510.1186/s12885-025-15287-2
No abstract available for this study.